Table 6.
Failure and mortality rates reported in prior studies for two-stage revision TKA.
| Reference (authors) | Year | Failure defined | Number of knees | Mean follow-up (months) | Failure rate (%) | Overall mortality rate (%) | 90-day mortality rate (%) |
|---|---|---|---|---|---|---|---|
| Current study | 2013 | Persistent infection | 66 | 40 (0–113) | 24 | 23 (15/66) | 1.5 (1/66) |
| Cai et al. [19] | 2012 | Reinfection | 23 | 43 (24–60) | 9 | NR | NR |
| Kubista et al. [18] | 2012 | Reinfection | 368 | 43 (1–93.6) | 16 | NR | NR |
| Mahmud et al. [20] | 2012 | SSI | 253 | 12 (12–204) | 13 | NR | NR |
| Radoicic et al. [9] | 2012 | SSI | 21 | 35–47 | 24 | NR | NR |
| Tigani et al. [17] | 2013 | SSI | 38 | 65 (24–139) | 23.6 | NR | NR |
| Gooding et al. [21] | 2011 | Reinfection | 115 | 108 (60–144) | 12 | 30 (32/115) | NR |
| Sherrell et al.* [16] | 2011 | SSI | 83 | 50 (1–151) | 34 | 14 (12/83) | NR |
| Mortazavi et al. [14] | 2011 | SSI | 117 | 41 (24–113) | 28 | NR | NR |
| Macheras et al. [22] | 2011 | Reinfection | 34 | 145 (120–168) | 9 | NR | NR |
| Kurd et al. [23] | 2010 | SSI | 96 | 35 (24–90) | 27 | NR | NR |
| Kosters et al. [24] | 2009 | Reinfection | 6 | 25 (2–61) | 0 | NR | NR |
| Hofmann et al. [25] | 2005 | Reinfection | 50 | 74 (24–150) | 12 | 22 (11/50) | NR |
| Average | 17.3 | 22 |
SSI = subsequent surgery for reinfection; NR = not reported.
*Two-Stage after failed I&D.